Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
uniQure N.V. - Ordinary Shares
(NQ:
QURE
)
24.16
-0.35 (-1.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about uniQure N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
uniQure BLA Filed as AMT-130 Shows 4-Year Huntington’s Functional Benefit
↗
September 29, 2026
uniQure (NASDAQ:QURE) reported updated Phase I/II data for its investigational Huntington’s disease gene therapy, ifezuntirgene inilparvovec, or AMT-130, including 36-month results from all high-dose...
Via
MarketBeat
Top movers analysis one hour before the close of the markets on 2026-09-29: top gainers and losers in today's session.
↗
September 29, 2026
Via
Chartmill
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law
September 29, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
UniQure (NASDAQ:QURE) Rises on Pipeline Progress Despite Wider Q2 Loss
↗
July 29, 2026
Via
Chartmill
These stocks are moving in today's session
↗
September 29, 2026
Via
Chartmill
QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
September 29, 2026
From
Kehoe Law Firm
Via
GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
September 29, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Tuesday.
↗
September 29, 2026
Via
Chartmill
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
September 29, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
September 02, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure (QURE) Q2 2026 Earnings Call Transcript
↗
August 07, 2026
Gene therapy biotech secures FDA alignment for Huntington's disease BLA submission.
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 30, 2026
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million. uniQure...
Via
Benzinga
uniQure Q2 Earnings Call Highlights
↗
July 29, 2026
uniQure (NASDAQ:QURE) said it has aligned with the U.S. Food and Drug Administration on a potential accelerated-approval pathway for AMT-130, its investigational gene therapy for Huntington's disease,...
Via
MarketBeat
Topics
Earnings
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
July 29, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure to Announce Second Quarter 2026 Financial Results
July 22, 2026
~ uniQure to host earnings call on Wednesday, July 29, 2026 at 8:30 a.m. ET ~
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
June 25, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Pricing of Upsized $225 Million Public Offering
June 23, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces $150 Million Proposed Public Offering
June 22, 2026
From
uniQure Inc.
Via
GlobeNewswire
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now
↗
June 19, 2026
Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV (QURE) opened around $43. Touched $48.88 intraday. Closed in the high $47s....
Via
InvestorPlace
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
June 19, 2026
From
uniQure Inc.
Via
GlobeNewswire
Top movers in Wednesday's session
↗
June 17, 2026
Via
Chartmill
These stocks are moving in today's session
↗
June 17, 2026
Via
Chartmill
Gapping stocks in Wednesday's session
↗
June 17, 2026
Via
Chartmill
Discover the top movers in Wednesday's pre-market session.
↗
June 17, 2026
Via
Chartmill
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
June 17, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May 05, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
April 30, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure to Announce First Quarter 2026 Financial Results
April 28, 2026
From
uniQure Inc.
Via
GlobeNewswire
QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
April 13, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
April 13, 2026
From
Schall Law
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
